Cardiopulmonary and neuromodulation devices with 50+ years of clinical heritage
LivaNova manufactures implantable cardiac and neuromodulation devices across 100+ countries, operating a 3,000-person organization. The tech stack reveals a mature enterprise: SAP / S/4HANA for supply-chain backbone, embedded systems (STM32, NXP, Renesas microcontrollers running C/C++), CAD/PLM (AutoCAD, PTC Creo + Windchloe), and BI (Power BI). Hiring velocity is accelerating across engineering, healthcare, and sales — consistent with active projects spanning firmware development for heart-lung machines, U.S. sales build-out, and patient monitoring integration.
Notable leadership hires: Patient Marketing Director, Project Head, Neuromodulation Project Head, Head of Sales
LivaNova PLC is a publicly traded medical-technology company (Nasdaq: LIVN) headquartered in London with ~3,000 employees and presence in more than 100 countries. The company manufactures implantable devices and systems in two core areas: cardiopulmonary (heart-lung machines, perfusion systems) and neuromodulation (vagus nerve stimulation). Revenue streams combine hardware sales, clinical services, and patient-support programs. The organization operates a global supply chain and regulatory-compliance apparatus spanning FDA, CE, and international approvals — reflected in core pain points around new FDA requirements and implementation barriers.
Enterprise: Salesforce, SAP S/4HANA, Workday, Power BI, Azure DevOps. Embedded: STM32, NXP, Renesas microcontrollers; C/C++, FreeRTOS, Zephyr. Design: AutoCAD, PTC Creo, Ansys, MATLAB. Currently adopting SAP.
Heart-lung machine firmware, U.S. sales organization launch, patient monitoring system (Essenz) integration, neuromodulation product initiatives, clinical registries, and global patient-marketing strategy.
Other companies in the same industry, closest in size